We’re thrilled to share that our CEO and Founder, Stella Sarraf, PhD, has been named to Forbes 2025 Class of 50 Over 50: Innovation list.
This recognition celebrates trailblazers who are redefining what’s possible in science, technology, and business—and we couldn’t be prouder to see Stella honored for her bold vision and unwavering commitment to advancing novel therapies in Alzheimer’s disease, ALS, schizophrenia and other diseases where synapses are affected.
Thank you to Forbes for recognizing the impact of Stella’s work and the broader mission of Spinogenix.